Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: A Belgian hospital;Recherche de Staphylococcus aureus à sensibilité diminuée à la vancomycine dans un hôpital Belge

Pathologie Biologie

Volumn 52, Issue 8, 2004, Pages 486-488

  Pierard D ^a   Vandenbussche, H ^a   Verschraegen, I ^a   Lauwers, S ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Glycopeptides; MRSA; Staphylococcus aureus; Vancomycin; VISA

Indexed keywords

AGAR; GLYCOPEPTIDE;

ARTICLE; AWARENESS; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM COLONY; BACTERIUM ISOLATION; CULTURE MEDIUM; DRUG RESISTANCE; DRUG SENSITIVITY; HOSPITAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SCREENING; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BELGIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 4744359801     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.07.016     Document Type: Article

References (7)

1. EARSS annual report 2002 Bilthoven 2003 National Institute of Public Health and the Environment The Netherlands
2. Brief report: vancomycin-resistant Staphylococcus aureusNew York, 2004 MMWR 53 2004 322 323
3. K. Hiramatsu, N. Avitaka, H. Hanari, S. Kawasaki, Y. Hosoda, and S. Hori Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin Lancet 350 1997 1670 1673
4. C. Gemmel Glycopeptide resistance in Staphylococcus aureus: is it a real threat? J. Infect. Chemother. 10 2004 69 75
5. Communiqu 2004 2004 Socit Franaise de Microbiologie Paris
6. T. Walsh, A. Bolmstrm, A. Qwrnstrm, P. Ho, M. Wootton, and R. Howe Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides J. Clin. Microbiol. 39 2001 2439 2444
7. O. Denis, C. Nonhoff, B. Byl, C. Knoop, S. Bobin-Dubreux, and M. Struelens Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features J. Antimicrob. Chemother. 50 2002 383 391